Skip to main content

previous disabled Page of 6
and
  1. No Access

    Article

    End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial

    Response determined by 18[F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomography (PET)–CT after induction therapy can predict progression-free survival (PFS) in follicular lymphoma (FL). However, litt...

    Koji Kato, Koji Izutsu, Momoko Nishikori in International Journal of Hematology (2024)

  2. Article

    Open Access

    Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial

    Acute graft-versus-host disease (aGvHD) is a major complication after allogeneic hematopoietic stem cell transplantation in Japan and other countries. Nearly one-third of patients do not respond to standard sy...

    Takanori Teshima, Yasushi Onishi, Koji Kato in International Journal of Hematology (2024)

  3. No Access

    Article

    Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review

    We report a rare case of spontaneous regression (SR) in an elderly untreated patient with multiple solitary plasmacytoma (MSP). Diagnosis of MSP was confirmed through surgical resection of the left nasal cavit...

    Wataru Kitamura, Hiroki Kobayashi, Minori Noda in International Journal of Hematology (2024)

  4. Article

    Open Access

    Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma

    Although chimeric antigen receptor T-cell (CAR-T) therapies have dramatically improved the outcomes of relapsed/refractory B-cell malignancies, recipients suffer from severe humoral immunodeficiencies. Further...

    Kenta Hayashino, Keisuke Seike, Kanako Fujiwara in International Journal of Hematology (2024)

  5. No Access

    Article

    JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)

    Yoshinobu Maeda in International Journal of Hematology (2024)

  6. No Access

    Article

    Cold agglutinin–induced acrocyanosis without hemolytic anemia

    Wataru Kitamura, Hiroki Kobayashi, Akiko Iseki, Hideho Wada in Annals of Hematology (2024)

  7. No Access

    Article

    Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral develo** T cells in thymoma, with special reference to PD-1 expression

    Though programmed cell death-1 (PD-1) inhibitors mainly target tumor-infiltrating lymphocytes (TILs) expressing PD-1, develo** T cells in thymus also express PD-1 in their process of maturation. To predict t...

    Tatsuo Furuya, Shunta Ishihara, Hiroshi Ogi in Cancer Immunology, Immunotherapy (2023)

  8. No Access

    Article

    More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance

    Combination therapy with immune checkpoint inhibitors (ICIs) and chemotherapy (ICI + chemotherapy) has become the standard first line treatment for driver oncogene-negative advanced non-small-cell lung cancer ...

    Chihiro Ando, Eiki Ichihara in Journal of Cancer Research and Clinical On… (2023)

  9. No Access

    Article

    Force exerted on maxillary anterior teeth in mandibular unilateral and bilateral distal extension partial edentulous situation

    The purpose of this study was to determine the influence of mandibular unilateral and bilateral distal extension partial edentulous situation and the use of removable partial dental prostheses on the force exe...

    Hitomi Togawa, Tomoya Gonda, Takeshi Karino, Yoshinobu Maeda, Takahiro Ono in Odontology (2023)

  10. Article

    Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation

    Non-infectious pulmonary complications (NIPCs) after allogeneic hematopoietic stem cell transplantation (HSCT) are associated with poor outcomes. It is important to maximize the effectiveness of primary treatm...

    Yui Kambara, Nobuharu Fujii, Yoshiaki Usui in International Journal of Hematology (2023)

  11. Article

    Open Access

    Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testing

    Amid the Coronavirus Disease 2019 pandemic, we aimed to demonstrate the accuracy of the fingertip whole blood sampling test (FWT) in measuring the antibody titer and uncovering its dynamics shortly after boost...

    Hideharu Hagiya, Yasuhiro Nakano, Masanori Furukawa, Naruhiko Sunada in Scientific Reports (2022)

  12. Article

    Open Access

    ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial

    Darbepoetin alfa (DA) is used to treat anemia in lower-risk (IPSS low or int-1) myelodysplastic syndromes (MDS). However, whether mutations can predict the effectiveness of DA has not been examined. The presen...

    Yasuyoshi Morita, Yasuhito Nannya, Motoshi Ichikawa in International Journal of Hematology (2022)

  13. No Access

    Article

    Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis

    A 44-year-old Japanese man presented with fever and sore throat. He had a history of refractory chronic sinusitis that did not respond to several years of pharmacotherapy, and underwent endoscopic sinus surger...

    Wataru Kitamura, Hideaki Fujiwara, Akifumi Matsumura in International Journal of Hematology (2022)

  14. No Access

    Article

    Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801

    The role of pembrolizumab in the treatment of poor performance status (PS) patients remains unclear.

    Shinobu Hosokawa, Eiki Ichihara in International Journal of Clinical Oncology (2022)

  15. No Access

    Article

    Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group

    Progression-free survival in patients with untreated follicular lymphoma (FL) has significantly improved with obinutuzumab plus chemotherapy followed by obinutuzumab maintenance, compared with rituximab plus c...

    Yuki Fujiwara, Tomohiro Urata, Daigo Niiya in International Journal of Hematology (2022)

  16. No Access

    Article

    Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group

    Previous studies have revealed that relapse of myeloid neoplasms after allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be predicted by monitoring Wilms’ tumor 1 (WT1) mRNA expression. Howe...

    Wataru Kitamura, Nobuharu Fujii, Yuichiro Nawa in International Journal of Hematology (2022)

  17. No Access

    Article

    A case of redo tricuspid valve repair after neonatal cone operation for Ebstein’s anomaly

    Cone reconstruction for Ebstein’s anomaly, although effective, is challenging in neonatal cases. Very few reports have discussed recurrent regurgitation. Herein, we report a successful redo tricuspid valve rep...

    Junya Nabeshima, Masaaki Yamagishi in General Thoracic and Cardiovascular Surgery (2022)

  18. Article

    Open Access

    Identification of targetable kinases in idiopathic pulmonary fibrosis

    Tyrosine kinase activation plays an important role in the progression of pulmonary fibrosis. In this study, we analyzed the expression of 612 kinase-coding and cancer-related genes using next-generation sequen...

    Hisao Higo, Kadoaki Ohashi, Shuta Tomida, Sachi Okawa in Respiratory Research (2022)

  19. No Access

    Chapter

    Endometrial Hyperplasia without Atypia

    Endometrial hyperplasia without atypia (as in the 2020 WHO classification) is defined as the proliferation of endometrial glands of irregular size and shape without significant cytological atypia. The ratio of...

    Yoshinobu Maeda, Takeshi Nishikawa in The Yokohama System for Reporting Endometr… (2022)

  20. No Access

    Chapter

    Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia

    Endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia (EAH/EIN) is defined as the simultaneous appearance of cytological atypia in endometrial glands and an increased ratio of endometrial gla...

    Yoshinobu Maeda, Akihiko Kawahara in The Yokohama System for Reporting Endometr… (2022)

previous disabled Page of 6